Department of Psychology, University of Connecticut, United States
Mini Review
Delivery of Anti-Hiv Drugs of Targeting Strategies
Author(s): Ankit Mishra*
Infection with the human immunodeficiency virus continues to be a leading cause of death worldwide. The current antiretroviral therapy has a number of drawbacks, including toxicity, drug-drug interactions, the development of drug resistance, the need for long-term drug therapy, poor bioavailability, and lack of access to tissues and reservoirs, even though it has significantly decreased AIDS-related morbidity and mortality. Recent anti-HIV therapeutic research has concentrated on developing drug delivery methods that are selectively targeted to host cells that are HIV-infected or at risk of becoming HIV-positive in order to get around these issues. In this context, a number of surface molecules with both viral and host cell cellular origins have been identified in recent years, which might allow for the targeted administration of drugs to HIV-infected individuals. In this review, we g.. View More»
DOI: 2572-5475-09.01-125
Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi 